133 related articles for article (PubMed ID: 10395488)
21. Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.
Löschmann PA; De Groote C; Smith L; Wüllner U; Fischer G; Kemp JA; Jenner P; Klockgether T
Exp Neurol; 2004 May; 187(1):86-93. PubMed ID: 15081591
[TBL] [Abstract][Full Text] [Related]
22. Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.
Gregory TF; Wright JL; Wise LD; Meltzer LT; Serpa KA; Konkoy CS; Whittemore ER; Woodward RM
Bioorg Med Chem Lett; 2000 Mar; 10(6):527-9. PubMed ID: 10741546
[TBL] [Abstract][Full Text] [Related]
23. Subtype-selective antagonism of NMDA receptors by nylidrin.
Whittemore ER; Ilyin VI; Konkoy CS; Woodward RM
Eur J Pharmacol; 1997 Oct; 337(2-3):197-208. PubMed ID: 9430414
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
25. Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues.
Kornberg BE; Nikam SS; Wright JL; Kesten SR; Meltzer LT; Coughenour L; Barr B; Serpa KA; McCormick J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1213-6. PubMed ID: 14980668
[TBL] [Abstract][Full Text] [Related]
26. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
[TBL] [Abstract][Full Text] [Related]
27. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
28. Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.
Steece-Collier K; Chambers LK; Jaw-Tsai SS; Menniti FS; Greenamyre JT
Exp Neurol; 2000 May; 163(1):239-43. PubMed ID: 10785463
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
[TBL] [Abstract][Full Text] [Related]
30. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
Mov Disord; 2006 Jan; 21(1):9-17. PubMed ID: 16127720
[TBL] [Abstract][Full Text] [Related]
31. Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
Savola JM; Hill M; Engstrom M; Merivuori H; Wurster S; McGuire SG; Fox SH; Crossman AR; Brotchie JM
Mov Disord; 2003 Aug; 18(8):872-83. PubMed ID: 12889076
[TBL] [Abstract][Full Text] [Related]
32. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
35. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
37. Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.
Frølund S; Bella A; Kristensen AS; Ziegler HL; Witt M; Olsen CA; Strømgaard K; Franzyk H; Jaroszewski JW
J Med Chem; 2010 Oct; 53(20):7441-51. PubMed ID: 20873775
[TBL] [Abstract][Full Text] [Related]
38. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
39. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
40. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
